NASDAQ

Updated Oct 30, 9:34 AM ET

LGND

Ligand Pharmaceuticals Inc.

+$0.79 (0.25%) Today

Oct 30, 9:34 AM ET

About LGND

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

News

0 latest

No recent news for LGND.

Headlines open the publisher's site.